Emerging therapeutic alternatives for snakebite envenoming
Αποθηκεύτηκε σε:
| Συγγραφέας: | |
|---|---|
| Μορφή: | contribución de congreso |
| Ημερομηνία έκδοσης: | 2019 |
| Περιγραφή: | The primary treatment for snakebite envenoming remains the administration of animal-derived antivenoms. While highly effective against systemic manifestations, antivenoms present drawbacks, including the need for trained healthcare staff, limited specificity (being restricted to the venoms used in immunization), and the risk of adverse reactions. |
| Χώρα: | Kérwá |
| Ίδρυμα: | Universidad de Costa Rica |
| Repositorio: | Kérwá |
| Γλώσσα: | Inglés |
| OAI Identifier: | oai:kerwa.ucr.ac.cr:10669/104658 |
| Διαθέσιμο Online: | https://hdl.handle.net/10669/104658 https://doi.org/10.1016/j.toxicon.2019.06.044 |
| Λέξη-Κλειδί : | Snakebite envenoming Antivenoms Recombinant antibodies Toxin inhibitors Phospholipases A2 Metalloproteinases Nanoparticles |